脂質ナノ粒子原料の世界市場規模調査・予測：製品別、適応症別、用途別、最終用途別、地域別分析、2023年～2030年

脂質ナノ粒子原料の世界市場は、2022年に約2億1,247万米ドルと評価され、予測期間2023年～2030年には5.66%以上の健全な成長率で成長すると予測されています。

脂質ナノ粒子（LNP）は、脂質分子からなる微細な球状構造体であり、薬物、遺伝子、治療薬を細胞内に輸送するように設計されています。脂質ナノ粒子原料は、脂質ナノ粒子（LNP）の作成と製造に利用される成分です。脂質ナノ粒子は、細胞への浸透という点で課題をもたらす可能性のある多様な分子を送達するための汎用性の高いプラットフォームを提供するため、医療分野におけるその重要性は急速に高まっています。デリバリーシステムとして脂質ナノ粒子を利用するドラッグへの需要の高まり、ナノテクノロジーへの注目の高まり、ドラッグデリバリーシステムに対する需要の高まり、市場企業間のジョイントベンチャーやパートナーシップの普及の高まりなどが、世界全体の市場需要を促進している最も顕著な要因です。さらに、がん、心血管障害、自己免疫疾患などの慢性疾患の有病率の上昇は、市場の成長をさらに促進すると予想されます。がんの発生率の増加は、製薬およびバイオテクノロジー分野における脂質ナノ粒子（LNP）の原料の必要性に影響を及ぼしています。米国がん協会によると、2024年の米国における新規がん罹患者数は2,001,140人、がん関連死亡者数は611,720人と推定されています。LNPは抗がん剤を送達するための有望な手段であり、多様な薬物を圧縮し、薬物の溶解性を向上させ、腫瘍部位への薬物送達を増強する能力を提供します。この需要の急増は、LNP合成に不可欠な原材料の必要性を後押ししています。

さらに、さまざまな治療用途のドラッグデリバリーシステムなど、脂質ナノ粒子をベースとした新規製品の開発を目的とした研究開発プロジェクトには、政府からの資金援助が欠かせないです。さらに、市場の拡大は、大手企業が研究開発能力への投資を増やすことによって推進され、その結果、技術改良が促進され、市場の見通しが拡大し、技術革新が促進されます。例えば、エボニックは2022年6月、米国に総投資額2億2,000万米ドルの大規模な医薬品脂質合成工場を新設する計画を発表しました。米国政府はこの構想に対し、Biomedical Advanced Research and Development Authority（BARDA）から最大1億5,000万米ドルを融資しています。さらに、医薬品の研究開発の増加、遺伝子治療やワクチンへの応用の拡大は、予測される数年間にさまざまな有利な機会をもたらします。しかし、高い市場開拓コストと、承認と商業化に関連する厳しい規制が、2023年～2030年の予測期間を通じて市場成長の妨げとなっています。

脂質ナノ粒子原料の世界市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカです。北米は、製薬およびバイオテクノロジー分野の急成長により、2022年の市場を独占しました。さらに、米国とカナダの製薬会社やバイオテクノロジー企業による研究開発への投資の増加が、脂質ナノ粒子ベースのドラッグデリバリーシステムの需要を促進しています。北米における生物製剤や遺伝子治療製品へのシフトは、脂質ナノ粒子ベースの送達システムに新たな機会をもたらしています。これらのナノ粒子は、mRNA、siRNA、遺伝子編集ツールを含む核酸の効果的なキャリアであり、多様な疾患に対処します。COVID-19のmRNAワクチンが承認されたことで、遺伝子治療用途における脂質ナノ粒子の有望な可能性がさらに強調されました。さらに、アジア太平洋地域は予測期間中最も高いCAGRで成長すると予想されています。経済活動の急増が医療費の増加と医療研究開発への投資の増加につながり、この地域全体の市場需要を大きく押し上げています。また、ヘルスケアのインフラが進歩し、医療サービスへのアクセスが拡大するにつれて、革新的なドラッグデリバリーシステムに対する需要が高まっており、これが脂質ナノ粒子の需要を促進し、ひいては市場の拡大を後押ししています。さらに、アジア太平洋地域の政府は、助成金、補助金、奨励金を通じて、ライフサイエンス分野の研究開発イニシアチブをますます強化しています。例えば、中国の「メイド・イン・チャイナ2025」計画やインドの「バイオテクノロジー産業研究支援協議会」（BIRAC）のようなイニシアチブは、バイオテクノロジーにおける技術革新と起業家精神を積極的に促進しています。このような支援環境が脂質ナノ粒子の研究開発への投資を促進し、市場成長に大きく寄与しています。

本調査の目的は、近年のさまざまなセグメントと国の市場規模を定義し、今後数年間の値を予測することです。本レポートは、調査対象国における産業の質的・量的側面の両方を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題など、重要な側面に関する詳細情報も掲載しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

第2章 世界の脂質ナノ粒子原料市場の定義と範囲

• 調査目的
• 市場の定義と範囲
  • 産業の進化
  • 調査範囲
• 調査対象年
• 通貨換算レート

第3章 脂質ナノ粒子原料の世界市場力学

• 脂質ナノ粒子原料市場の影響分析（2020年～2030年）
  • 市場促進要因
    • 慢性疾患の増加
    • 政府の資金援助と支援の増加
  • 市場の課題
    • 高い開発コスト
    • 承認と商業化に関連する厳しい規制
  • 市場機会
    • 医薬品の研究開発の増加
    • 遺伝子治療やワクチンへの応用拡大

第4章 世界の脂質ナノ粒子原料市場の産業分析

• ポーターのファイブフォースモデル
  • 供給企業の交渉力
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争企業間の敵対関係
• ポーターのファイブフォース影響分析
• PEST分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 環境
  • 法律
• 主な投資機会
• 主要成功戦略
• COVID-19影響分析
• 破壊的動向
• 業界専門家の視点
• アナリストの結論・提言

第5章 脂質ナノ粒子原料の世界市場：製品別

• 市場スナップショット
• 脂質ナノ粒子原料の世界市場：製品別、実績 - ポテンシャル分析
• 脂質ナノ粒子原料の世界市場：製品別、推定・予測（2020年～2030年）
• 脂質ナノ粒子原料市場のサブセグメント分析
  • イオン化可能脂質
  • 試薬
  • その他の原料

第6章 脂質ナノ粒子原料の世界市場：適応症別

• 市場スナップショット
• 脂質ナノ粒子原料の世界市場：適応症別、実績 - ポテンシャル分析
• 脂質ナノ粒子原料の世界市場：適応症別、推定・予測（2020年～2030年）
• 脂質ナノ粒子原料市場のサブセグメント分析
  • がん
  • 感染症
  • 血液疾患
  • その他

第7章 脂質ナノ粒子原料の世界市場：用途別

• 市場スナップショット
• 脂質ナノ粒子原料の世界市場：用途別、実績 - ポテンシャル分析
• 脂質ナノ粒子原料の世界市場：用途別、推定・予測（2020年～2030年）
• 脂質ナノ粒子原料市場のサブセグメント分析
  • 治療薬
  • 研究

第8章 脂質ナノ粒子原料市場：最終用途別

• 市場スナップショット
• 脂質ナノ粒子原料の世界市場：最終用途別、実績 - ポテンシャル分析
• 脂質ナノ粒子原料の世界市場：最終用途別、推定・予測（2020年～2030年）
• 脂質ナノ粒子原料市場のサブセグメント分析
  • 製薬・バイオテクノロジー企業
  • 学術・研究機関
  • その他

第9章 脂質ナノ粒子原料の世界市場：地域別分析

• 主要国
• 主な新興国
• 脂質ナノ粒子原料の世界市場：地域別の市場スナップショット
• 北米
  • 米国
    • 製品別の推定・予測、（2020年～2030年）
    • 適応症別の推定・予測、（2020年～2030年）
    • 用途別の推定・予測、（2020年～2030年）
    • 最終用途別の推定・予測、（2020年～2030年）
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • スペイン
  • イタリア
  • その他欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • オーストラリア
  • 韓国
  • その他アジア太平洋
• ラテンアメリカ
  • ブラジル
  • メキシコ
• 中東・アフリカ
  • サウジアラビア
  • 南アフリカ
  • その他中東・アフリカ

第10章 競合情報

• 主要企業のSWOT分析
• 主要市場戦略
• 企業プロファイル
  • Merck KGaA
    • 主要情報
    • 概要
    • 財務（データの入手可能性によります）
    • 製品概要
    • 最近の動向
  • Echelon Biosciences
  • BroadPharm
  • Avanti Polar Lipids
  • Tebubio
  • CordenPharma International
  • Creative Biolabs
  • Biopharma PEG Scientific Inc.
  • NOF AMERICA CORPORATION
  • Polysciences, Inc.

第11章 調査プロセス

• 調査プロセス
  • データマイニング
  • 分析
  • 市場推定
  • 検証
  • 出版
• 調査属性
• 調査前提条件

LIST OF TABLES

• TABLE 1.Global Lipid Nanoparticle Raw Materials Market, report scope
• TABLE 2.Global Lipid Nanoparticle Raw Materials Market estimates & forecasts by Region 2020-2030 (USD Million)
• TABLE 3.Global Lipid Nanoparticle Raw Materials Market estimates & forecasts by Product 2020-2030 (USD Million)
• TABLE 4.Global Lipid Nanoparticle Raw Materials Market estimates & forecasts by Disease Indication 2020-2030 (USD Million)
• TABLE 5.Global Lipid Nanoparticle Raw Materials Market estimates & forecasts by Application 2020-2030 (USD Million)
• TABLE 6.Global Lipid Nanoparticle Raw Materials Market estimates & forecasts by End-use 2020-2030 (USD Million)
• TABLE 7.Global Lipid Nanoparticle Raw Materials Market by segment, estimates & forecasts, 2020-2030 (USD Million)
• TABLE 8.Global Lipid Nanoparticle Raw Materials Market by region, estimates & forecasts, 2020-2030 (USD Million)
• TABLE 9.Global Lipid Nanoparticle Raw Materials Market by segment, estimates & forecasts, 2020-2030 (USD Million)
• TABLE 10.Global Lipid Nanoparticle Raw Materials Market by region, estimates & forecasts, 2020-2030 (USD Million)
• TABLE 11.Global Lipid Nanoparticle Raw Materials Market by segment, estimates & forecasts, 2020-2030 (USD Million)
• TABLE 12.Global Lipid Nanoparticle Raw Materials Market by region, estimates & forecasts, 2020-2030 (USD Million)
• TABLE 13.Global Lipid Nanoparticle Raw Materials Market by segment, estimates & forecasts, 2020-2030 (USD Million)
• TABLE 14.Global Lipid Nanoparticle Raw Materials Market by region, estimates & forecasts, 2020-2030 (USD Million)
• TABLE 15.Global Lipid Nanoparticle Raw Materials Market by segment, estimates & forecasts, 2020-2030 (USD Million)
• TABLE 16.Global Lipid Nanoparticle Raw Materials Market by region, estimates & forecasts, 2020-2030 (USD Million)
• TABLE 17.U.S. Lipid Nanoparticle Raw Materials Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 18.U.S. Lipid Nanoparticle Raw Materials Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 19.U.S. Lipid Nanoparticle Raw Materials Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 20.Canada Lipid Nanoparticle Raw Materials Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 21.Canada Lipid Nanoparticle Raw Materials Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 22.Canada Lipid Nanoparticle Raw Materials Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 23.UK Lipid Nanoparticle Raw Materials Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 24.UK Lipid Nanoparticle Raw Materials Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 25.UK Lipid Nanoparticle Raw Materials Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 26.Germany Lipid Nanoparticle Raw Materials Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 27.Germany Lipid Nanoparticle Raw Materials Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 28.Germany Lipid Nanoparticle Raw Materials Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 29.France Lipid Nanoparticle Raw Materials Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 30.France Lipid Nanoparticle Raw Materials Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 31.France Lipid Nanoparticle Raw Materials Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 32.Italy Lipid Nanoparticle Raw Materials Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 33.Italy Lipid Nanoparticle Raw Materials Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 34.Italy Lipid Nanoparticle Raw Materials Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 35.Spain Lipid Nanoparticle Raw Materials Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 36.Spain Lipid Nanoparticle Raw Materials Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 37.Spain Lipid Nanoparticle Raw Materials Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 38.RoE Lipid Nanoparticle Raw Materials Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 39.RoE Lipid Nanoparticle Raw Materials Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 40.RoE Lipid Nanoparticle Raw Materials Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 41.China Lipid Nanoparticle Raw Materials Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 42.China Lipid Nanoparticle Raw Materials Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 43.China Lipid Nanoparticle Raw Materials Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 44.India Lipid Nanoparticle Raw Materials Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 45.India Lipid Nanoparticle Raw Materials Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 46.India Lipid Nanoparticle Raw Materials Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 47.Japan Lipid Nanoparticle Raw Materials Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 48.Japan Lipid Nanoparticle Raw Materials Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 49.Japan Lipid Nanoparticle Raw Materials Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 50.South Korea Lipid Nanoparticle Raw Materials Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 51.South Korea Lipid Nanoparticle Raw Materials Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 52.South Korea Lipid Nanoparticle Raw Materials Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 53.Australia Lipid Nanoparticle Raw Materials Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 54.Australia Lipid Nanoparticle Raw Materials Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 55.Australia Lipid Nanoparticle Raw Materials Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 56.RoAPAC Lipid Nanoparticle Raw Materials Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 57.RoAPAC Lipid Nanoparticle Raw Materials Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 58.RoAPAC Lipid Nanoparticle Raw Materials Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 59.Brazil Lipid Nanoparticle Raw Materials Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 60.Brazil Lipid Nanoparticle Raw Materials Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 61.Brazil Lipid Nanoparticle Raw Materials Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 62.Mexico Lipid Nanoparticle Raw Materials Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 63.Mexico Lipid Nanoparticle Raw Materials Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 64.Mexico Lipid Nanoparticle Raw Materials Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 65.RoLA Lipid Nanoparticle Raw Materials Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 66.RoLA Lipid Nanoparticle Raw Materials Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 67.RoLA Lipid Nanoparticle Raw Materials Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 68.Saudi Arabia Lipid Nanoparticle Raw Materials Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 69.South Africa Lipid Nanoparticle Raw Materials Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 70.RoMEA Lipid Nanoparticle Raw Materials Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 71.List of secondary sources, used in the study of global Lipid Nanoparticle Raw Materials Market
• TABLE 72.List of primary sources, used in the study of global Lipid Nanoparticle Raw Materials Market
• TABLE 73.Years considered for the study
• TABLE 74.Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

• FIG 1.Global Lipid Nanoparticle Raw Materials Market, research methodology
• FIG 2.Global Lipid Nanoparticle Raw Materials Market, Market estimation techniques
• FIG 3.Global Market size estimates & forecast methods
• FIG 4.Global Lipid Nanoparticle Raw Materials Market, key trends 2022
• FIG 5.Global Lipid Nanoparticle Raw Materials Market, growth prospects 2023-2030
• FIG 6.Global Lipid Nanoparticle Raw Materials Market, porters 5 force model
• FIG 7.Global Lipid Nanoparticle Raw Materials Market, pest analysis
• FIG 8.Global Lipid Nanoparticle Raw Materials Market, value chain analysis
• FIG 9.Global Lipid Nanoparticle Raw Materials Market by segment, 2020 & 2030 (USD Million)
• FIG 10.Global Lipid Nanoparticle Raw Materials Market by segment, 2020 & 2030 (USD Million)
• FIG 11.Global Lipid Nanoparticle Raw Materials Market by segment, 2020 & 2030 (USD Million)
• FIG 12.Global Lipid Nanoparticle Raw Materials Market by segment, 2020 & 2030 (USD Million)
• FIG 13.Global Lipid Nanoparticle Raw Materials Market by segment, 2020 & 2030 (USD Million)
• FIG 14.Global Lipid Nanoparticle Raw Materials Market, regional snapshot 2020 & 2030
• FIG 15.North America Lipid Nanoparticle Raw Materials Market 2020 & 2030 (USD Million)
• FIG 16.Europe Lipid Nanoparticle Raw Materials Market 2020 & 2030 (USD Million)
• FIG 17.Asia Pacific Lipid Nanoparticle Raw Materials Market 2020 & 2030 (USD Million)
• FIG 18.Latin America Lipid Nanoparticle Raw Materials Market 2020 & 2030 (USD Million)
• FIG 19.Middle East & Africa Lipid Nanoparticle Raw Materials Market 2020 & 2030 (USD Million)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

Global Lipid Nanoparticle Raw Materials Market is valued at approximately USD 212.47 million in 2022 and is anticipated to grow with a healthy growth rate of more than 5.66% over the forecast period 2023-2030. Lipid nanoparticles (LNPs) are microscopic spherical structures composed of lipid molecules, designed to transport drugs, genes, or therapeutic agents into cells. Lipid nanoparticle raw materials are the components utilized in the creation and manufacturing of lipid nanoparticles (LNPs). Their significance in the medical field is growing rapidly as they offer a versatile platform for delivering a diverse range of molecules that might pose challenges in terms of cellular penetration. The growing demand for drugs utilizing lipid nanoparticles as delivery systems, increasing focus on nanotechnology, growing demand for drug delivery systems, along the rising prevalence of joint ventures and partnerships among market players are the most prominent factors that are propelling the market demand across the globe. Additionally, the rising prevalence of chronic diseases like cancer, cardiovascular disorders, and autoimmune conditions is anticipated to further bolster market growth. The rise in incidences of cancer influences the need for raw materials for Lipid Nanoparticles (LNPs) within the pharmaceutical and biotechnology sectors. According to the American Cancer Society for 2024 estimated 2,001,140 new cancer cases and 611,720 cancer-related deaths in the U.S. The increase in cancer prevalence fuels the demand for effective cancer treatments. LNPs present a promising avenue for delivering anticancer drugs, offer their capacity to compress diverse drugs, improve drug solubility, and augment drug delivery to tumour sites. This surge in demand propels the need for raw materials essential in LNP synthesis.

Moreover, government funding is crucial for R&D projects aimed at developing novel lipid nanoparticle-based products, such as drug delivery systems for a variety of therapeutic uses. Furthermore, the market's expansion is propelled by leading players' increasing investment in research and development capabilities, which in turn fosters technical improvements, expands market prospects, and promotes innovation. For instance, in June 2022, Evonik announced plans to build a new, large-scale pharmaceutical lipid synthesis factory in the United States with a total investment of USD 220 million. The U.S. government has provided up to USD 150 million for this initiative with financing from the Biomedical Advanced Research and Development Authority (BARDA). Furthermore, the rise in pharmaceutical research and development, as well as the expanding applications in gene therapy and vaccines presents various lucrative opportunities over the forecasting years. However, the high development costs, along with the stringent regulations related to the approval and commercialization are hindering the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Lipid Nanoparticle Raw Materials Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the rapid growth of the pharmaceutical and biotechnology sectors. Additionally, growing investments in research and development by pharmaceutical companies and biotech enterprises in the United States and Canada are driving the demand for lipid nanoparticle-based drug delivery systems. The shift towards biologics and gene therapy products in North America has created new opportunities for lipid nanoparticle-based delivery systems. These nanoparticles are effective carriers for nucleic acids, including mRNA, siRNA, and gene-editing tools, to address diverse diseases. The approval of mRNA vaccines for COVID-19 has further underscored the promising potential of lipid nanoparticles in gene therapy applications. Moreover, Asia Pacific is expected to grow at the highest CAGR over the forecast years. The surge in economic activity, leading to growing healthcare expenditure and increased investments in medical research and development is significantly propelling the market demand across the region. Also, there is a rising demand for innovative drug delivery systems as healthcare infrastructure advances and access to medical services broadens, which is propelling the demand for lipid nanoparticles and, in turn, augments market expansion. Moreover, governments across the Asia Pacific region are increasingly bolstering research and development initiatives in the life sciences sector through grants, subsidies, and incentives. For instance, Initiatives like China's "Made in China 2025" plan and India's "Biotechnology Industry Research Assistance Council" (BIRAC) are actively promoting innovation and entrepreneurship in biotechnology. This supportive environment fosters investments in lipid nanoparticle research and development, thereby contributing significantly to market growth.

Major market players included in this report are:

• Merck KGaA
• Echelon Biosciences
• BroadPharm
• Avanti Polar Lipids
• Tebubio
• CordenPharma International
• Creative Biolabs
• Biopharma PEG Scientific Inc.
• NOF AMERICA CORPORATION
• Polysciences, Inc.

Recent Developments in the Market:

• In July 2023, Cytiva launched a formulation system tailored to streamline the seamless manufacturing of lipid nanoparticle medicines throughout both clinical and commercial phases. This system simplifies operations, fostering efficient and holistic production of lipid nanoparticle-based medications from initial development to full commercialization. Cytiva's formulation system for lipid nanoparticle medicines is poised to have a positive market impact by improving efficiency, accelerating development, expanding market reach, providing a competitive advantage, and ensuring regulatory compliance, ultimately benefiting both companies and patients.
• In July 2023, ModernaTX, Inc. and McGill University announced their strategic collaboration aimed at advancing research in lipid nanoparticle (LNP) technology. The collaboration encompasses two innovative projects concentrating on the exploration of specific facets of LNP properties, potentially including their characteristics or comparisons to naturally occurring particles. The collaboration between ModernaTX, Inc. and McGill University is driving innovation, attract funding, boost competitiveness, and leading for regulatory approvals in lipid nanoparticle technology, leading to significant market impact.

Global Lipid Nanoparticle Raw Materials Market Report Scope:

• Historical Data - 2020 - 2021
• Base Year for Estimation - 2022
• Forecast period - 2023-2030
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered - Product, Disease Indication, Application, End-use, Region
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope - Free report customization (equivalent to up to 8 analysts' working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define the market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters to detailed information about the crucial aspects such as driving factors & challenges that will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

• Ionizable lipids
• Reagents
• Other raw materials

By Disease Indication:

• Cancer
• Infectious Diseases
• Blood Diseases
• Others

By Application:

• Therapeutics
• Research

By End-use:

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Others

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Table of Contents

Chapter 1.Executive Summary

• 1.1.Market Snapshot
• 1.2.Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
  • 1.2.1.Lipid Nanoparticle Raw Materials Market, by Region, 2020-2030 (USD Million)
  • 1.2.2.Lipid Nanoparticle Raw Materials Market, by Product, 2020-2030 (USD Million)
  • 1.2.3.Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2020-2030 (USD Million)
  • 1.2.4.Lipid Nanoparticle Raw Materials Market, by Application, 2020-2030 (USD Million)
  • 1.2.5.Lipid Nanoparticle Raw Materials Market, by End-use, 2020-2030 (USD Million)
• 1.3.Key Trends
• 1.4.Estimation Methodology
• 1.5.Research Assumption

Chapter 2.Global Lipid Nanoparticle Raw Materials Market Definition and Scope

• 2.1.Objective of the Study
• 2.2.Market Definition & Scope
  • 2.2.1.Industry Evolution
  • 2.2.2.Scope of the Study
• 2.3.Years Considered for the Study
• 2.4.Currency Conversion Rates

Chapter 3.Global Lipid Nanoparticle Raw Materials Market Dynamics

• 3.1.Lipid Nanoparticle Raw Materials Market Impact Analysis (2020-2030)
  • 3.1.1.Market Drivers
    • 3.1.1.1.Increasing prevalence of chronic diseases
    • 3.1.1.2.Rising government funding and support
  • 3.1.2.Market Challenges
    • 3.1.2.1.High development costs
    • 3.1.2.2.Stringent regulations related to the approval and commercialization
  • 3.1.3.Market Opportunities
    • 3.1.3.1.Rise in the pharmaceutical research and development
    • 3.1.3.2.Expanding applications in gene therapy and vaccines

Chapter 4.Global Lipid Nanoparticle Raw Materials Market Industry Analysis

• 4.1.Porter's 5 Force Model
  • 4.1.1.Bargaining Power of Suppliers
  • 4.1.2.Bargaining Power of Buyers
  • 4.1.3.Threat of New Entrants
  • 4.1.4.Threat of Substitutes
  • 4.1.5.Competitive Rivalry
• 4.2.Porter's 5 Force Impact Analysis
• 4.3.PEST Analysis
  • 4.3.1.Political
  • 4.3.2.Economical
  • 4.3.3.Social
  • 4.3.4.Technological
  • 4.3.5.Environmental
  • 4.3.6.Legal
• 4.4.Top investment opportunity
• 4.5.Top winning strategies
• 4.6.COVID-19 Impact Analysis
• 4.7.Disruptive Trends
• 4.8.Industry Expert Perspective
• 4.9.Analyst Recommendation & Conclusion

Chapter 5.Global Lipid Nanoparticle Raw Materials Market, by Product

• 5.1.Market Snapshot
• 5.2.Global Lipid Nanoparticle Raw Materials Market by Product, Performance - Potential Analysis
• 5.3.Global Lipid Nanoparticle Raw Materials Market Estimates & Forecasts by Product 2020-2030 (USD Million)
• 5.4.Lipid Nanoparticle Raw Materials Market, Sub Segment Analysis
  • 5.4.1.Ionizable lipids
  • 5.4.2.Reagents
  • 5.4.3.Other raw materials

Chapter 6.Global Lipid Nanoparticle Raw Materials Market, by Disease Indication

• 6.1.Market Snapshot
• 6.2.Global Lipid Nanoparticle Raw Materials Market by Disease Indication, Performance - Potential Analysis
• 6.3.Global Lipid Nanoparticle Raw Materials Market Estimates & Forecasts by Disease Indication 2020-2030 (USD Million)
• 6.4.Lipid Nanoparticle Raw Materials Market, Sub Segment Analysis
  • 6.4.1.Cancer
  • 6.4.2.Infectious Diseases
  • 6.4.3.Blood Diseases
  • 6.4.4.Others

Chapter 7.Global Lipid Nanoparticle Raw Materials Market, by Application

• 7.1.Market Snapshot
• 7.2.Global Lipid Nanoparticle Raw Materials Market by Application, Performance - Potential Analysis
• 7.3.Global Lipid Nanoparticle Raw Materials Market Estimates & Forecasts by Application 2020-2030 (USD Million)
• 7.4.Lipid Nanoparticle Raw Materials Market, Sub Segment Analysis
  • 7.4.1.Therapeutics
  • 7.4.2.Research

Chapter 8.Lipid Nanoparticle Raw Materials Market, by End-use

• 8.1.Market Snapshot
• 8.2.Global Lipid Nanoparticle Raw Materials Market by End-use, Performance - Potential Analysis
• 8.3.Global Lipid Nanoparticle Raw Materials Market Estimates & Forecasts by End-use 2020-2030 (USD Million)
• 8.4.Lipid Nanoparticle Raw Materials Market, Sub Segment Analysis
  • 8.4.1.Pharmaceutical & Biotechnology Companies
  • 8.4.2.Academic & Research Institutes
  • 8.4.3.Others

Chapter 9.Global Lipid Nanoparticle Raw Materials Market, Regional Analysis

• 9.1.Top Leading Countries
• 9.2.Top Emerging Countries
• 9.3.Lipid Nanoparticle Raw Materials Market, Regional Market Snapshot
• 9.4.North America Lipid Nanoparticle Raw Materials Market
  • 9.4.1.U.S. Lipid Nanoparticle Raw Materials Market
    • 9.4.1.1.Product breakdown estimates & forecasts, 2020-2030
    • 9.4.1.2.Disease Indication breakdown estimates & forecasts, 2020-2030
    • 9.4.1.3.Application breakdown estimates & forecasts, 2020-2030
    • 9.4.1.4.End-use breakdown estimates & forecasts, 2020-2030
  • 9.4.2.Canada Lipid Nanoparticle Raw Materials Market
• 9.5.Europe Lipid Nanoparticle Raw Materials Market Snapshot
  • 9.5.1.U.K. Lipid Nanoparticle Raw Materials Market
  • 9.5.2.Germany Lipid Nanoparticle Raw Materials Market
  • 9.5.3.France Lipid Nanoparticle Raw Materials Market
  • 9.5.4.Spain Lipid Nanoparticle Raw Materials Market
  • 9.5.5.Italy Lipid Nanoparticle Raw Materials Market
  • 9.5.6.Rest of Europe Lipid Nanoparticle Raw Materials Market
• 9.6.Asia-Pacific Lipid Nanoparticle Raw Materials Market Snapshot
  • 9.6.1.China Lipid Nanoparticle Raw Materials Market
  • 9.6.2.India Lipid Nanoparticle Raw Materials Market
  • 9.6.3.Japan Lipid Nanoparticle Raw Materials Market
  • 9.6.4.Australia Lipid Nanoparticle Raw Materials Market
  • 9.6.5.South Korea Lipid Nanoparticle Raw Materials Market
  • 9.6.6.Rest of Asia Pacific Lipid Nanoparticle Raw Materials Market
• 9.7.Latin America Lipid Nanoparticle Raw Materials Market Snapshot
  • 9.7.1.Brazil Lipid Nanoparticle Raw Materials Market
  • 9.7.2.Mexico Lipid Nanoparticle Raw Materials Market
• 9.8.Middle East & Africa Lipid Nanoparticle Raw Materials Market
  • 9.8.1.Saudi Arabia Lipid Nanoparticle Raw Materials Market
  • 9.8.2.South Africa Lipid Nanoparticle Raw Materials Market
  • 9.8.3.Rest of Middle East & Africa Lipid Nanoparticle Raw Materials Market

Chapter 10.Competitive Intelligence

• 10.1.Key Company SWOT Analysis
• 10.2.Top Market Strategies
• 10.3.Company Profiles
  • 10.3.1.Merck KGaA
    • 10.3.1.1.Key Information
    • 10.3.1.2.Overview
    • 10.3.1.3.Financial (Subject to Data Availability)
    • 10.3.1.4.Product Summary
    • 10.3.1.5.Recent Developments
  • 10.3.2.Echelon Biosciences
  • 10.3.3.BroadPharm
  • 10.3.4.Avanti Polar Lipids
  • 10.3.5.Tebubio
  • 10.3.6.CordenPharma International
  • 10.3.7.Creative Biolabs
  • 10.3.8.Biopharma PEG Scientific Inc.
  • 10.3.9.NOF AMERICA CORPORATION
  • 10.3.10.Polysciences, Inc.

Chapter 11.Research Process

• 11.1.Research Process
  • 11.1.1.Data Mining
  • 11.1.2.Analysis
  • 11.1.3.Market Estimation
  • 11.1.4.Validation
  • 11.1.5.Publishing
• 11.2.Research Attributes
• 11.3.Research Assumption